Abstract:Objective: To explore the clinical and molecular genetic features of patients with Alagille syndrome (AS). Methods: The clinical data of eleven pediatric patients, who were suspected to have AS at the Department of Pediatrics in the First Affiliated Hospital of Jinan University from August 2010 to March 2017, were collected and analyzed. Genomic DNA was extracted from peripheral blood leukocytes of the patients and their parents. For 5 patients collected before March 2006, all JAG1 exons and their flanking sequences were directly sequenced. For the remaining 6 patients, high-throughput gene capture technology, chromosomal microarray analysis (CMA) and whole-genome copy-number variant(CNV) analysis were utilized, when necessary, to explore the genetic causes. Results: All patients had cholestasis. However, the γ-glutamyl transpeptidase (GGT) levels in one patient were normal. Nine patients had posterior embryotoxon and facial malformations. Eight patients displayed heart defects. Seven patients presented with vertebral anomalies and among them, 1 patient had sacralization of the cubitus and radius. The condition of nine patients tended to be stabilized on follow-up, but 1 patient died of liver failure in late infancy and 1 got worse. Seven JAG1 variants were detected in 9 out of the 11 AS patients, with c.1977G>A (p.Trp659*) and c.1106_1107delCC (p.Pro369fs) being two novel variants. Two heterozygous interstitial deletions of 3.0 Mb and 9.24 Mb in size, respectively, in chromosome 20 were discovered in the remaining 2 patients. Both deletions involved the entire JAG1 gene. De novo origin was unveiled for the detected variants in 7 patients and interstitial deletions in two. Although the mother of 2 patients carried the relevant variant, she did not demonstrate any clinical features of AS. Conclusions: With cholestasis, posterior embryotoxon, facial malformations, heart defects and vertebral anomalies being the major manifestations, AS demonstrated variable clinical expressivities and incomplete penetrance. This study identified a total of 7 JAG1 variants as well as 2 interstitial deletions involving this gene, and among them, the variants c.1977G>A (p.Trp659* ) and c.1106_1107delCC (p.Pro369fs) as well as the 9.24 Mb chromosomal interstitial deletion had not been reported previously.

JAG1 Loss‑of‑function Mutations Contributed to Alagille Syndrome in Two Chinese Families.

Targeted Sequencing and RNA Assay Reveal a Noncanonical JAG1 Splicing Variant Causing Alagille Syndrome.

Alagille Syndrome is Caused by Mutations in Human Jagged1, Which Encodes A Ligand for Notch1

Analysis of JAG1 Gene Variant in Chinese Patients with Alagille Syndrome.

Jag1 Mutation Spectrum And Origin In Chinese Children With Clinical Features Of Alagille Syndrome

Mutation Analysis of Jagged1 (JAG1) in Alagille Syndrome Patients Communicated by Ian McIntosh Online Citation: Human Mutation, Mutation in Brief #397 (2000) Online Http://Journals.wiley.com/1059-7794/Pdf/mutation/397.pdf

[Identification of a Novel JAG1 Mutation in a Family Affected by Alagille Syndrome].

Novel JAG1 variants leading to Alagille syndrome in two Chinese cases

JAGGED1 gene variations in Chinese twin sisters with Alagille syndrome

Conditional JAG1 Mutation Shows the Developing Heart is More Sensitive Than Developing Liver to JAG1 Dosage

[Clinical and Genetic Analysis of Eleven Pediatric Patients with Alagille Syndrome].

De Novo Jag1 Gene Deletion Causes Atypical Severe Alagille Syndrome In A Chinese Child

Case Report: Novel JAG1 Gene Mutations in Two Infants with Alagille Syndrome Characterized by Cholestasis

Advances in the Research of Molecular Genetics of Alagille Syndrome

A novel JAG1 frameshift variant causing Alagille syndrome with incomplete penetrance

Balanced Translocation Disrupting JAG1 Identified by Optical Genomic Mapping in Suspected Alagille Syndrome

[Clinical and Genetic Study of an Infant with Alagille Syndrome: Identification of a Novel Chromosomal Interstitial Deletion Including JAG1 Gene].

A Chinese Girl Molecularly Diagnosed with Alagille Syndrome.

Defining pathogenicity of <i>NOTCH2</i> variants for diagnosis of Alagille syndrome type 2 using a large cohort of patients

Jagged-mediated development and disease: Mechanistic insights and therapeutic implications for Alagille syndrome

Investigation of cryptic JAG1 splice variants as a cause of Alagille syndrome and performance evaluation of splice predictor tools